Prognostic significance of homocysteine levels in acute ischemic stroke: A prospective cohort study

Current Neurovascular Research

Volumn 12, Issue 4, 2015, Pages 334-340

  Ji, Yan ^a   Song, Bo ^a   Xu, Yuming ^a   Fang, Hui ^a   Wu, Jun ^a   Sun, Shilei ^a   Zhao, Lu ^a   Shi, Changhe ^a   Gao, Yuan ^a   Tao, Yongli ^a   Li, Yapeng ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Homocysteine; Modified Rankin Scale; National Institutes of Health Stroke Scale; Prognosis; Prospective study; Stroke

Indexed keywords

HOMOCYSTEINE;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CHINESE; COHORT ANALYSIS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RECURRENT DISEASE; REFERENCE VALUE; SMOKING HABIT; TRANSIENT ISCHEMIC ATTACK; URBAN POPULATION; BLOOD; COMPLICATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; NONPARAMETRIC TEST; SENSITIVITY AND SPECIFICITY; STROKE;

AGED; BRAIN ISCHEMIA; COHORT STUDIES; FEMALE; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; STROKE;

EID: 84942119049     PISSN: 15672026     EISSN: 18755739     Source Type: Journal    
DOI: 10.2174/1567202612666150807112205     Document Type: Article

References (32)

1. Karim MA, Majumder AA, Islam KQ, et al. Risk factors and inhospital outcome of acute ST segment elevation myocardial infarction in young Bangladeshi adults. BMC Cardiovasc Disord. 2015; 15(1):73.
2. Catena C, Colussi G, Nait F, Capobianco F, Sechi LA. Elevated Homocysteine Levels Are Associated With the Metabolic Syndrome and Cardiovascular Events in Hypertensive Patients. Am J Hypertens. 2015;28(7):943-950
3. Schaffer A, Verdoia M, Cassetti E, et al. Relationship between homocysteine and coronary artery disease. Results from a large prospective cohort study. Thromb Res. 2014;134(2):288-293.
4. Omland T, Samuelsson A, Hartford M, et al. Serum homocysteine concentration as an indicator of survival in patients with acute coronary syndromes. Arch Intern Med. 2000; 160(12): 1834-1840.
5. Smith RK, Quigley F, Tosenovsky et al. Serum homocysteine is associated with the severity of primary chronic venous disease. Phlebology. 2015; Epub ahead of print.
6. Zhang W., Sun K, Chen J., et al. High plasma homocysteine levels contribute to the risk of stroke recurrence and all-cause mortality in a large prospective stroke population. Clinical Science.2009; 118(3): 187-194.
7. Yan J, Liao JK, Wang D. Elevated Homocysteine and C-reactive Protein Levels Independently Predict Worsening Prognosis after Stroke in Chinese Patients. J Huazhong Univ Sci Technolog Med Sci. 2010; 30(5): 643-647.
8. Ganguly PK, Maddaford TG, Edel AL, O K, Smeda JS, Pierce GN. Increased homocysteine-induced release of excitatory amino acids in the striatum of spontaneously hypertensine stroke-prone rats. Brain Res. 2008; 1226: 192-198.
9. Poddar R, Paul S. Homocysteine-NMDA receptor-mediated activation of extracellular signal-regulated kinase leads to neuronal cell death. J Neurochem. 2009; 110(3): 1095-1106.
10. Organization WH. Stroke-1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders. Stroke.1989; 20(10): 1407-1431.
11. Adams HP, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993; 24(1): 35-41.
12. Duncan PW, Zorowitz R, Bates B, et al. Management of Adult Stroke Rehabilitation Care: A Clinical Practice Guideline. Stroke. 2005; 36(9): e100-e143.
13. Weisscher N, Vermeulen M, Roos YB, de Haan RJ. What should be defined as good outcome in stroke trials; a modified Rankin score of 0-1 or 0-2? J Neurol. 2008; 255(6): 867-874.
14. Men X, Li J, Zhang B, Zhang L, Li H, Lu Z. Homocysteine and Creactive protein associated with progression and prognosis of intracranial branch atheromatous disease. PLoS One. 2013; 8(9): e73030.
15. Gong X, Zou X, Liu L, et al. Prognostic value of inflammatory mediators in 1-year outcome of acute ischemic stroke with middle cerebral artery stenosis. Mediators Inflamm. 2013; 2013: 850714.
16. Pniewski J, Chodakowska-Zebrowska M, Woźniak R, Stepień K, Stafiej A. Plasma homocysteine level and the course of ischemic stroke. Acta Neurobiol Exp (Wars). 2003; 63(2): 127-130.
17. Hyung-Min Kwon, Yong-Seok Lee, Hee-Joon Bae, Dong-Wha Kang. Homocysteine as a Predictor of Early Neurological Deterioration in Acute Ischemic Stroke. Stroke. 2014; 45(3): 871-873.
18. Okubadejo NU, Oladipo OO, Adeyomoye AA, Awosanya GO, Danesi MA. Exploratory study of plasma total homocysteine and its relationship to short term outcome in acute ischaemic stroke in Nigerians. BMC Neurol. 2008; 8:26.
19. Hernández-Betancor I, Martín-Ponce E, Martínez-Riera A, et al. Prognostic value of serum homocysteine levels in elderly hospitalized patients. Nutr Hosp. 2015; 31(6): 2590-2597.
20. Song IU, Kim JS, Ryu SY, Lee SB, Lee SJ, Jeong DS, et al. Are plasma homocysteine levels related to neurological severity and functional outcome after ischemic stroke in the Korean population? J Neurol Sci. 2009; 278(1-2): 60-63.
21. Zhong C, Lv L, Liu C, et al. High Homocysteine and Blood Pressure Related to Poor Outcome of Acute Ischemia Stroke in Chinese Population. PLOS ONE. 2014; 9(9): e107498.
22. Nygård O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med. 1997; 337(4): 230-236.
23. Sacco RL, Adams R, Albers G, et al. Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack. A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke Co-Sponsored by the Council on Cardiovascular Radiology and Intervention. The American Academy of Neurology affirms the value of this guideline. Circulation. 2006;113(10):e409-e449
24. Shao J, Yan J, Ye H, et al. Plasma homocysteine level associated with microalbuminuria in Chinese people. Chin J Internal Med. 2003; 42(4): 283-284.
25. Chen SF, Cui CL, Wu P, Xie NZ. Relationship of serum homocysteine level with nutritional status and HbA1c level in elderly inpatients. Int J Clin Exp Med. 2013; 6(9): 779-784.
26. Chen S, Wu P, Zhou L, Shen Y, Li Y, Song H. Relationship between increase of serum homocysteine caused by smoking and oxidative damage in elderly patients with cardiovascular disease. Int J Clin Exp Med. 2015; 8(3): 4446-4454.
27. Fang P, Zhang D, Cheng Z, Yan C, Jiang X, Kruger WD, et al. Hyperhomocysteinemia Potentiates Hyperglycemia-induced Inflammatory Monocyte Differentiation and Atherosclerosis. Diabetes. 2014; 63(12): 4275-4290.
28. Graham IM, Daly LE, Refsum HM, et al. Plasma homoeysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA. 1997; 277(22): 1775-1781
29. Hu DY, Xu XP, New idea about primary prevention of H type hypertension. Chin J Internal Med. 2008, 47(12): 976-977
30. Wang C, Han L, Wu Q, et al. Association between homocysteine and incidence of ischemic stroke in subjects with essential hypertension: a matched case-control study. Clin Exp Hypertens. 2015; 20:1-6. [Epub ahead of print]
31. Qu Y, Zhang HL, Yu LM, Sun Y, Wu HL, Chen YG. Aldehyde dehydrogenase 2 polymorphism as a protective factor for intracranial vascular stenosis in ischemic stroke in Han Chinese. Int J Neurosci. 2015:1-6. [Epub ahead of print]
32. Chen QY, Liu N, Ma J, et al. Effect of a pre-microRNA-149 (miR- 149) genetic variation on the risk of ischemic stroke in a Chinese Han population. Genet Mol Res. 2015; 14(1): 2582-2589.